相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Nivolumab Plus Relatlimab: First Approval
Julia Paik
DRUGS (2022)
Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanoma
Justin C. Moser et al.
ACTA ONCOLOGICA (2020)
TNFSF14: LIGHTing the Way for Effective Cancer Immunotherapy
Joseph G. Skeate et al.
FRONTIERS IN IMMUNOLOGY (2020)
A decade of immune-checkpoint inhibitors in cancer therapy
Caroline Robert
NATURE COMMUNICATIONS (2020)
Regulation of PD-L1 Expression by NF-κB in Cancer
Fabrizio Antonangeli et al.
FRONTIERS IN IMMUNOLOGY (2020)
Diphencyprone as a therapeutic option in cutaneous metastasis of melanoma. A single-institution experience
Ivana Lameiras Gibbons et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2018)
Immune checkpoint inhibitors: recent progress and potential biomarkers
Pramod Darvin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
LAMPs: Shedding light on cancer biology
Federica Alessandrini et al.
SEMINARS IN ONCOLOGY (2017)
Contact immunotherapy enhances the therapeutic effects of nivolumab in treating in-transit melanoma: Two cases reports
Taku Fujimura et al.
JOURNAL OF DERMATOLOGY (2016)
Definite regression of cutaneous melanoma metastases upon addition of topical contact sensitizer diphencyprone to immune checkpoint inhibitor treatment
Nicholas Gulati et al.
EXPERIMENTAL DERMATOLOGY (2016)
Molecular Profiling of Immune Activation Associated with Regression of Melanoma Metastases Induced by Diphencyprone
Nicholas Gulati et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Chemokine CXCL1 mediated neutrophil recruitment: Role of glycosaminoglycan interactions
Kirti V. Sawant et al.
SCIENTIFIC REPORTS (2016)
CD70: An emerging target in cancer immunotherapy
J. Jacobs et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Nivolumab in NSCLC: latest evidence and clinical potential
Raghav Sundar et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2015)
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases
Alessandro Antonelli et al.
AUTOIMMUNITY REVIEWS (2014)
Topical Immunotherapy with Diphencyprone for in Transit and Cutaneously Metastatic Melanoma
Diona L. Damian et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)